Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001327776 | SCV001518865 | uncertain significance | Ullrich congenital muscular dystrophy 2; Bethlem myopathy 2 | 2020-03-12 | criteria provided, single submitter | clinical testing | This variant has not been reported in the literature in individuals with COL12A1-related conditions. This sequence change replaces proline with glutamine at codon 2971 of the COL12A1 protein (p.Pro2971Gln). The proline residue is highly conserved and there is a moderate physicochemical difference between proline and glutamine. This variant is not present in population databases (ExAC no frequency). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |